Analysis of rare copy number variation in absence epilepsies

Objective: To identify shared genes and pathways between common absence epilepsy (AE) subtypes (childhood absence epilepsy [CAE], juvenile absence epilepsy [JAE], and unclassified absence epilepsy [UAE]) that may indicate common mechanisms for absence seizure generation and potentially a diagnostic continuum. Methods: We used high-density single-nucleotide polymorphism arrays to analyze genome-wide rare copy number variation (CNV) in a cohort of 144 children with AEs (95 CAE, 26 UAE, and 23 JAE). Results: We identified CNVs that are known risk factors for AE in 4 patients, including 3x 15q11.2 deletion. We also expanded the phenotype at 4 regions more commonly identified in other neurodevelopmental disorders: 1p36.33 duplication, 1q21.1 deletion, 22q11.2 duplication, and Xp22.31 deletion and duplication. Fifteen patients (10.5%) were found to carry rare CNVs that disrupt genes associated with neuronal development and function (8 CAE, 2 JAE, and 5 UAE). Four categories of protein are each disrupted by several CNVs: (1) synaptic vesicle membrane or vesicle endocytosis, (2) synaptic cell adhesion, (3) synapse organization and motility via actin, and (4) gap junctions. CNVs within these categories are shared across the AE subtypes. Conclusions: Our results have reinforced the complex and heterogeneous nature of the AEs and their potential for shared genetic mechanisms and have highlighted several pathways that may be important in epileptogenesis of absence seizures. Neurol Genet 2016;2:e56; doi:

[1]  Timothy J. Mosca.  On the Teneurin track: a new synaptic organization molecule emerges , 2015, Front. Cell. Neurosci..

[2]  Christian Gieger,et al.  Burden Analysis of Rare Microdeletions Suggests a Strong Impact of Neurodevelopmental Genes in Genetic Generalised Epilepsies , 2015, PLoS genetics.

[3]  Zi Chen,et al.  Common Variants of KCNJ10 Are Associated with Susceptibility and Anti-Epileptic Drug Resistance in Chinese Genetic Generalized Epilepsies , 2015, PloS one.

[4]  A. Hannan,et al.  Reduced susceptibility to induced seizures in the Neuroligin-3R451C mouse model of autism , 2015, Neuroscience Letters.

[5]  S. Gabriel,et al.  Biallelic truncating mutations in FMN2, encoding the actin-regulatory protein Formin 2, cause nonsyndromic autosomal-recessive intellectual disability. , 2014, American journal of human genetics.

[6]  S. Auvin,et al.  WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation , 2014, Journal of Medical Genetics.

[7]  A. Battaglia,et al.  Nine patients with Xp22.31 microduplication, cognitive deficits, seizures, and talipes anomalies , 2014, American journal of medical genetics. Part A.

[8]  J. McNamara,et al.  Antiseizure effects of TrkB kinase inhibition , 2014, Epilepsia.

[9]  J. Hallak,et al.  Neurotrophin receptors expression in mesial temporal lobe epilepsy with and without psychiatric comorbidities and their relation with seizure type and surgical outcome , 2014, Acta neuropathologica communications.

[10]  H. Mefford.  CNVs in Epilepsy , 2014, Current Genetic Medicine Reports.

[11]  P. Carlen,et al.  Roles of gap junctions, connexins, and pannexins in epilepsy , 2014, Front. Physiol..

[12]  R. Williams,et al.  Quantitative trait loci mapping and gene network analysis implicate protocadherin‐15 as a determinant of brain serotonin transporter expression , 2014, Genes, brain, and behavior.

[13]  G. Moonen,et al.  Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis , 2014, Neuropathology and applied neurobiology.

[14]  Y. Shigeri,et al.  Identification of amphiphysin 1 as an endogenous substrate for CDKL5, a protein kinase associated with X-linked neurodevelopmental disorder. , 2013, Archives of biochemistry and biophysics.

[15]  D. Rujescu,et al.  KCNIP4 as a candidate gene for personality disorders and adult ADHD , 2013, European Neuropsychopharmacology.

[16]  Holger Lerche,et al.  Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy , 2013, Epilepsia.

[17]  H. Mefford,et al.  Exon‐disrupting deletions of NRXN1 in idiopathic generalized epilepsy , 2013, Epilepsia.

[18]  Pablo M. Casillas-Espinosa,et al.  Regulators of synaptic transmission: Roles in the pathogenesis and treatment of epilepsy , 2012, Epilepsia.

[19]  S. Kitsiou‐Tzeli,et al.  Further delineation of novel 1p36 rearrangements by array-CGH analysis: narrowing the breakpoints and clarifying the "extended" phenotype. , 2012, Gene.

[20]  Edouard Hirsch,et al.  Epileptic encephalopathies of the Landau‐Kleffner and continuous spike and waves during slow‐wave sleep types: Genomic dissection makes the link with autism , 2012, Epilepsia.

[21]  C. Redies,et al.  Cadherins and neuropsychiatric disorders , 2012, Brain Research.

[22]  J. Sweatt,et al.  Enhanced Hippocampal Long-Term Potentiation and Fear Memory in Btbd9 Mutant Mice , 2012, PloS one.

[23]  O. Yalçin.  Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies , 2012, Seizure.

[24]  J. Rosenfeld,et al.  Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function , 2011, European Journal of Human Genetics.

[25]  J. Velíšková,et al.  Targeting Pannexin1 Improves Seizure Outcome , 2011, PloS one.

[26]  P. Striano,et al.  A clinical and genetic study of 33 new cases with early-onset absence epilepsy , 2011, Epilepsy Research.

[27]  S. Schwartz,et al.  Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay , 2011, Human Genetics.

[28]  Ulrich Stephani,et al.  Genome-Wide Copy Number Variation in Epilepsy: Novel Susceptibility Loci in Idiopathic Generalized and Focal Epilepsies , 2010, PLoS genetics.

[29]  K. Shen,et al.  Guidance molecules in synapse formation and plasticity. , 2010, Cold Spring Harbor perspectives in biology.

[30]  L. Nashef,et al.  Idiopathic Generalized Epilepsy with Absences: Syndrome Classification , 2007, Epilepsia.

[31]  Aaron,et al.  Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans. , 2006, Journal of neurosurgery.

[32]  D. Clapham,et al.  SynGAP-MUPP1-CaMKII Synaptic Complexes Regulate p38 MAP Kinase Activity and NMDA Receptor- Dependent Synaptic AMPA Receptor Potentiation , 2004, Neuron.

[33]  K. Nocka,et al.  The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  I. Scheffer,et al.  Genetic Architecture of Idiopathic Generalized Epilepsy: Clinical Genetic Analysis of 55 Multiplex Families , 2004, Epilepsia.

[35]  P. Sham,et al.  Haplotype and linkage disequilibrium analysis to characterise a region in the calcium channel gene CACNA1A associated with idiopathic generalised epilepsy , 2002, European Journal of Human Genetics.

[36]  T. Leung,et al.  The Myotonic Dystrophy Kinase-related Cdc42-binding Kinase Is Involved in the Regulation of Neurite Outgrowth in PC12 Cells* , 1999, The Journal of Biological Chemistry.

[37]  C. Baker,et al.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. , 2010, Brain : a journal of neurology.

[38]  P. McKeigue,et al.  Linkage and association analysis of CACNG 3 in childhood absence epilepsy , 2008 .

[39]  N. Barišić,et al.  Epileptic syndromes of infancy , 2005 .

[40]  G. Lynch,et al.  Integrins, synaptic plasticity and epileptogenesis. , 2004, Advances in experimental medicine and biology.

[41]  R. Mattson,et al.  Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. , 1989, Epilepsia.